ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
Ready to Win Big?
Try Now for Just $1!© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.
About 6.11% of NVCT shares are held by financial institutions. SUSQUEHANNA INTERNATIONAL GROUP, LLP is the top corporate investor, holding 0 shares valued at -. A 0% stake in Nuvectis Pharma, Inc. is owned by the company. GEODE CAPITAL MANAGEMENT, LLC owns 134.53K shares valued at $1.10M, which translates its holding of 0.77% of the stake in the company.
Among the NVCT insiders holding of 43.64% of the stake in company, BENTSUR RON, Chairman & CEO, holds the largest shares of 3.27M. MOSSERI MARLIO CHARLES, 10 percent owner, is the second largest NVCT insider with ownership of 2.88M shares. PORADOSU ENRIQUE, Chief Science & Business Off, stands third with possession of 1.51M shares of that stake.